Michael Banks, MD, discusses the risk for cirrhosis regression and liver cancer in patients with HCV-related cirrhosis who have already achieved SVR via DAA treatment.
In his last video, Garret Duron, MD, highlighted the recommendations that he and his team developed for how rheumatologists can navigate the COVID-19 literature landscape. In this video, Dr Duron explains...
Larry Smarr, Founding Director, CALIT2, details the growing epidemic of children, especially those with gastrointestinal disorders, who were not exposed to the necessary microbiomes during the formative...